Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1994-03-04
1997-05-06
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514551, 514564, 514824, A61K 3166, A61K 3122, A61K 31195
Patent
active
056271727
ABSTRACT:
A method is disclosed for lowering the concentration of a serum lipid or lipoprotein component in a mammal, including the step of administering to a mammal in need of such treatment a hypolipidemic, therapeutically effective amount of at least one creatine derivative.
REFERENCES:
patent: 5166142 (1992-11-01), Moss et al.
patent: 5219846 (1993-06-01), Bru et al.
patent: 5254549 (1993-10-01), Gold et al.
Balsom, et al., Creatine Supplementation and Dynamic High-Intensity Intermittent Exercise, Scand. J. Med. Sci. Sports 1993, 3:143-149.
Greenhaff, et al., Influence of Oral Creatine Supplementation of Muscle Torque During Repeated Bouts of Maximal Voluntary Exercise In Man, Clinical Science (1993) 84, 565-571 (Printed in Great Britain).
Sipil a, et al. Supplementary Creatine As A Treatment For Gyrate Atrophy Of The Choroid And Retina, N. Eng. J. Med., Apr. 9, 1981, 867-870.
Almada Anthony
Byrd Edward
Jordan Kimberly
Natural Supplement Association, Incorporated
LandOfFree
Method for reduction of serum blood lipids or lipoprotein fracti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reduction of serum blood lipids or lipoprotein fracti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reduction of serum blood lipids or lipoprotein fracti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2132774